Surgalign Holdings, Inc. Schedules Third Quarter 2021 Earnings Release for November 9, 2021
Surgalign Spine Technologies (NASDAQ: SRGA) plans to release its third quarter 2021 financial results on November 9, 2021, after market close. A conference call will follow at 4:30 p.m. ET, accessible by phone or via webcast on the company's investor website. Surgalign, dedicated to advancing digital surgery, markets its products in the U.S. and over 50 countries through a network of distributors. The firm emphasizes superior outcomes for patients and is strategically resourced to transform the surgical landscape.
- Focused on advancing the standard of care through digital surgery.
- Products marketed in over 50 countries, indicating a broad market reach.
- None.
DEERFIELD, Ill., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced it plans to release financial results from the third quarter 2021 after the close of trading on November 9, 2021.
Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 682-6100 (U.S.) or (862) 298-0702 (International), using conference ID 13724073. The webcast can be accessed through the investor section of Surgalign’s website at surgalign.com/investors/. A replay of the conference call will be available on Surgalign’s website for one month following the call.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital surgery and is building out its digital surgery platform to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies surgeons will look to for what is truly possible for their patients. Surgalign is focused on bringing surgeons solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw, Poland and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
Investor and Media Contact:
Mike Vallie
IR@surgalign.com
+1 443 213 0499
FAQ
When will Surgalign release its third quarter 2021 financial results?
What time is the conference call for Surgalign's Q3 2021 results?
What is the ticker symbol for Surgalign?
How can I access the webcast of Surgalign's conference call?
In how many countries does Surgalign market its products?
